Off-Label Indications, Expensive Therapies, Fast-Track Drugs: How Do PBMs Structure Prior Approval, Prescribing Restrictions, and Appeal Procedures?

Autor:	Michael Manolakis
Rok vydání:	2019
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::0432e11a8c74173565c480e6cdc9289f https://doi.org/10.1201/9781315272931-9 Zobrazit plný text záznamu